These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 1694023

  • 21. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G, Walia M, Bala H, Singh S.
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [Abstract] [Full Text] [Related]

  • 22. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N, Asano S, Matsuda S, Watari K, Takaku F, Nagata S.
    Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930
    [Abstract] [Full Text] [Related]

  • 23. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P, La Gamma EF.
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [Abstract] [Full Text] [Related]

  • 26. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M, Nomura H, Ono M, Bessho M, Hirashima K.
    Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
    [Abstract] [Full Text] [Related]

  • 27. Sex differences in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat.
    Tanaka H, Kaneko T.
    Drug Metab Dispos; 1991 Dec; 19(6):1034-9. PubMed ID: 1724959
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
    Tanaka H, Kaneko T.
    Drug Metab Dispos; 1991 Dec; 19(1):200-4. PubMed ID: 1708329
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K.
    J Immunol; 1991 Apr 15; 146(8):2639-47. PubMed ID: 1707914
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N, Chertkov J, Zander A.
    Exp Hematol; 1995 Oct 15; 23(11):1180-6. PubMed ID: 7556528
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, Kuma K, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1993 Nov 15; 77(5):1356-60. PubMed ID: 7521347
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
    Ahmad M, Fleit HB, Golightly MG, La Gamma EF.
    Biol Neonate; 2004 Nov 15; 86(1):48-54. PubMed ID: 15057022
    [Abstract] [Full Text] [Related]

  • 38. Comparison of two regimens of RhG-CSF in neutropenic neonatal septicemia: a randomized clinical trial.
    Nayeri F, Soheili H, Kaveh M, Oloomi Yazdi Z, Shariat M, Dalili H.
    Acta Med Iran; 2011 Nov 15; 49(9):575-8. PubMed ID: 22052139
    [Abstract] [Full Text] [Related]

  • 39. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR, Davies EG, Gibson FM, Gordon-Smith EC.
    Pediatr Res; 1995 May 15; 37(5):630-3. PubMed ID: 7541523
    [Abstract] [Full Text] [Related]

  • 40. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus.
    Frenck RW, Sarman G, Harper TE, Buescher ES.
    J Infect Dis; 1990 Jul 15; 162(1):109-14. PubMed ID: 2192004
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.